TI
DNTH icon

Trexquant Investment’s Dianthus Therapeutics DNTH Stock Holding History

Trexquant Investment’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Sell
20,729
-38,348
-65% -$3.35M 0.01% 1187
2026
Q1 		$4.96M Buy
59,077
+53,861
+1,033% +$3.12M 0.04% 651
2025
Q4 		$215K Buy
+5,216
New +$202K ﹤0.01% 1510
2020
Q3 		– Sell
-1,448
Closed -$174K – 1261
2020
Q2 		$174K Buy
+1,448
New +$204K 0.01% 1069

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Trexquant Investment's DNTH Position: Q2 2026 in Review

Trexquant Investment reduced its Dianthus Therapeutics (DNTH) stake by 65% in Q2 2026, selling an estimated $3.35M and leaving 20,729 shares worth $2.02M. The position accounts for 0.01% of the portfolio, ranked #1187.

Trexquant Investment first reported a position in DNTH in Q2 2020 and has held it in 4 quarters since. The position peaked at $4.96M in Q1 2026. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Trexquant Investment held 20,729 shares of Dianthus Therapeutics worth $2.02M as of Q2 2026.
  • Trexquant Investment sold 38,348 Dianthus Therapeutics shares in Q2 2026, an estimated $3.35M.
  • Dianthus Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1187 holding.
  • Trexquant Investment first reported a position in Dianthus Therapeutics in Q2 2020 and has held it in 4 quarters since.
  • Trexquant Investment's Dianthus Therapeutics position peaked at $4.96M in Q1 2026.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.